Malignant Digestive System Neoplasm — Trials

Malignant Digestive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19,101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,262
Recruiting: 2,363
Ph III recruiting: 292
Growth YoY: +13%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 28.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2,000)

clinicaltrialsPublishedShowing 251–285 of 285 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01859182	Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery	withdrawn	Phase 2	0	National Cancer Institute (NCI)NIH	0	Sep 9, 2014	clinicaltrials
NCT01722175	Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer(ALPPS)	withdrawn	Phase 2	0	Washington University School of MedicineOTHER